| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 12,508 | 7,678 | 7,575 | | Selling General and Administrative | 5,766 | 5,400 | 4,526 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (18,274) | (13,078) | (12,101) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 669 | 1,113 | 728 | | Earnings Before Interest And Taxes | (17,605) | (11,965) | (11,372) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (17,605) | (11,965) | (11,372) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (17,605) | (11,965) | (11,372) | | | Non-recurring Events | | Discontinued Operations |
-
| 28 | 781 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (17,605) | (11,937) | (10,591) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($17,605) | ($11,937) | ($10,591) |
|
1.48% Nasdaq 
0.34 (3.27%) 
Income Statement
